Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

C. Y. Cheah, D. Chihara, S. Horowitz, A. Sevin, Y. Oki, S. Zhou, N. H. Fowler, J. E. Romaguera, F. Turturro, F. B. Hagemeister, L. E. Fayad, M. Wang, S. S. Neelapu, L. J. Nastoupil, J. R. Westin, M. A. Rodriguez, F. Samaniego, P. Anderlini, Y. Nieto, Michelle A. Fanale

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences